Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51M Sell
146,023
-3,960
-3% -$1.41M 0.89% 22
2025
Q4
$49.1M Sell
149,983
-3,225
-2% -$1.02M 0.89% 18
2025
Q3
$43.2M Sell
153,208
-1,781
-1% -$517K 0.79% 23
2025
Q2
$43.3M Buy
154,989
+88,187
+132% +$25M 0.83% 23
2025
Q1
$20.8M Buy
66,802
+24,953
+60% +$7.37M 0.68% 32
2024
Q4
$10.9M Sell
41,849
-2,474
-6% -$734K 0.35% 63
2024
Q3
$14.3M Sell
44,323
-132
-0.3% -$43.2K 0.46% 49
2024
Q2
$13.9M Buy
44,455
+527
+1% +$155K 0.47% 50
2024
Q1
$12.5M Buy
43,928
+5,530
+14% +$1.62M 0.43% 59
2023
Q4
$11.1M Sell
38,398
-1,314
-3% -$358K 0.41% 61
2023
Q3
$10.7M Buy
39,712
+621
+2% +$155K 0.44% 62
2023
Q2
$8.68M Sell
39,091
-2,532
-6% -$588K 0.34% 75
2023
Q1
$10.1M Sell
41,623
-1,870
-4% -$459K 0.4% 59
2022
Q4
$11.4M Buy
43,493
+28,064
+182% +$7.52M 0.44% 58
2022
Q3
$3.48M Buy
15,429
+6,229
+68% +$1.51M 0.15% 126
2022
Q2
$2.24M Sell
9,200
-192
-2% -$47K 0.09% 180
2022
Q1
$2.27M Sell
9,392
-464
-5% -$107K 0.08% 201
2021
Q4
$2.22M Sell
9,856
-442
-4% -$93.3K 0.07% 221
2021
Q3
$2.19M Sell
10,298
-2,483
-19% -$572K 0.08% 214
2021
Q2
$3.12M Sell
12,781
-34,451
-73% -$8.48M 0.1% 177
2021
Q1
$11.8M Sell
47,232
-2,716
-5% -$648K 0.4% 63
2020
Q4
$11.5M Sell
49,948
-3,442
-6% -$794K 0.38% 62
2020
Q3
$13.6M Sell
53,390
-3,518
-6% -$872K 0.5% 43
2020
Q2
$13.4M Sell
56,908
-21,213
-27% -$4.84M 0.51% 44
2020
Q1
$15.8M Sell
78,121
-2,122
-3% -$463K 0.62% 31
2019
Q4
$19.3M Sell
80,243
-1,694
-2% -$373K 0.62% 26
2019
Q3
$15.9M Sell
81,937
-4,418
-5% -$848K 0.52% 34
2019
Q2
$15.9M Sell
86,355
-3,294
-4% -$590K 0.51% 34
2019
Q1
$17M Buy
89,649
+4,714
+6% +$900K 0.55% 27
2018
Q4
$16.5M Buy
84,935
+52,788
+164% +$10.3M 0.56% 27
2018
Q3
$6.67M Buy
32,147
+23,904
+290% +$4.71M 0.19% 181
2018
Q2
$1.52M Sell
8,243
-459
-5% -$81.2K 0.07% 253
2018
Q1
$1.48M Buy
8,702
+415
+5% +$76.2K 0.07% 252
2017
Q4
$1.44M Sell
8,287
-147
-2% -$26K 0.06% 278
2017
Q3
$1.57M Sell
8,434
-668
-7% -$118K 0.07% 234
2017
Q2
$1.57M Sell
9,102
-563
-6% -$91.6K 0.07% 231
2017
Q1
$1.59M Sell
9,665
-12,893
-57% -$2.14M 0.07% 229
2016
Q4
$3.3M Buy
22,558
+990
+5% +$149K 0.12% 211
2016
Q3
$3.6M Buy
21,568
+20,076
+1,346% +$3.39M 0.14% 201
2016
Q2
$227K Buy
+1,492
New +$232K 0.01% 510
2016
Q1
Sell
-2,667
Closed -$433K 515
2015
Q4
$433K Buy
2,667
+80
+3% +$12.6K 0.02% 455
2015
Q3
$358K Sell
2,587
-279
-10% -$44K 0.01% 468
2015
Q2
$458K Hold
2,866
0.02% 451
2015
Q1
$458K Buy
2,866
+1,065
+59% +$168K 0.02% 451
2014
Q4
$287K Sell
1,801
-368
-17% -$57.3K 0.01% 468
2014
Q3
$305K Sell
2,169
-179
-8% -$23.4K 0.01% 452
2014
Q2
$278K Sell
2,348
-23,478
-91% -$2.72M 0.01% 455
2014
Q1
$3.19M Sell
25,826
-159
-0.6% -$19.3K 0.12% 207
2013
Q4
$2.96M Sell
25,985
-311
-1% -$35.4K 0.12% 202
2013
Q3
$2.94M Sell
26,296
-2,508
-9% -$272K 0.14% 200
2013
Q2
$2.84M Buy
+28,804
New +$2.99M 0.14% 199

Other funds holding AMGN

Hancock Whitney's AMGN Position: Q1 2026 in Review

Hancock Whitney reduced its Amgen (AMGN) stake by 2.6% in Q1 2026, selling an estimated $1.41M and leaving 146,023 shares worth $51M. The position accounts for 0.89% of the portfolio, ranked #22.

Hancock Whitney first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hancock Whitney held 146,023 shares of Amgen worth $51M as of Q1 2026.
  • Hancock Whitney sold 3,960 Amgen shares in Q1 2026, an estimated $1.41M.
  • Amgen made up 0.89% of Hancock Whitney's portfolio in Q1 2026, its #22 holding.
  • Hancock Whitney first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.